| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, U.K.
A quantal assay, based on syncytium formation in the human T cell leukaemia-derived C8166 cell line, was used to determine the kinetics of human immuno-deficiency virus type 1 (HIV-1) strain IIIB neutralization. Three rat monoclonal antibodies (MAbs) were used, under physiological conditions of temperature and antibody concentration. MAb ICR39.3b (IgG2b) neutralized virus with no lag period while the other two MAbs, ICR39.13g (IgG2b) and ICR41.1i (IgG2a), neutralized with lag periods of 5 min and 15 min respectively. It was calculated that the latter two MAbs mediated neutralization by about two and three molecules of IgG per virion respectively. The highest neutralization rate constant (for MAb ICR 41.1i) was over 300-fold less than that of MAbs specific for the haemagglutinin of the enveloped influenza virus type A and for poliovirus type 1.
Received 21 July 1993;
accepted 16 December 1993.
This article has been cited by other articles:
|
|
 |
|
  R. Hernandez, A. Paredes, and D. T. Brown Sindbis Virus Conformational Changes Induced by a Neutralizing Anti-E1 Monoclonal Antibody J. Virol., June 15, 2008; 82(12): 5750 - 5760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Heap, Y. Wang, T. J. T. Pinheiro, S. A. Reading, K. R. Jennings, and N. J. Dimmock Analysis of a 17-amino acid residue, virus-neutralizing microantibody J. Gen. Virol., June 1, 2005; 86(6): 1791 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Heap, S. A. Reading, and N. J. Dimmock An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion J. Gen. Virol., May 1, 2005; 86(5): 1499 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, S. Kurteva, S. Lee, and J. Sodroski Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1 J. Virol., March 15, 2005; 79(6): 3500 - 3508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cheung, L. McLain, M. J. Hollier, S. A. Reading, and N. J. Dimmock Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion J. Gen. Virol., January 1, 2005; 86(1): 131 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Cleveland, L. McLain, L. Cheung, T. D. Jones, M. Hollier, and N. J. Dimmock A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion J. Gen. Virol., March 1, 2003; 84(3): 591 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Khiytani and N. J. Dimmock Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion J. Gen. Virol., October 1, 2002; 83(10): 2523 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Cleveland, T. D. Jones, and N. J. Dimmock Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1 J. Gen. Virol., May 1, 2000; 81(5): 1251 - 1260. [Abstract] [Full Text]
|
|
|
|
|
|
K. Schonning, O. Lund, O. Sogaard Lund, and J.-E. Stig Hansen Stoichiometry of Monoclonal Antibody Neutralization of T-Cell Line-Adapted Human Immunodeficiency Virus Type 1 J. Virol., October 1, 1999; 73(10): 8364 - 8370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Jackson, M Levi, B Wahren, and N. Dimmock Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions J. Gen. Virol., January 1, 1999; 80(1): 225 - 236. [Abstract]
|
|
|
|
 |
|
 A. De Logu, R. A. Williamson, R. Rozenshteyn, F. Ramiro-Ibañez, C. D. Simpson, D. R. Burton, and P. Paolo Sanna Characterization of a Type-Common Human Recombinant Monoclonal Antibody to Herpes Simplex Virus with High Therapeutic Potential J. Clin. Microbiol., November 1, 1998; 36(11): 3198 - 3204. [Abstract] [Full Text]
|
|
|
|
|
|
D. Cecilia, V. N. KewalRamani, J. O'Leary, B. Volsky, P. Nyambi, S. Burda, S. Xu, D. R. Littman, and S. Zolla-Pazner Neutralization Profiles of Primary Human Immunodeficiency Virus Type 1 Isolates in the Context of Coreceptor Usage J. Virol., September 1, 1998; 72(9): 6988 - 6996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. H. I. Parren, I. Mondor, D. Naniche, H. J. Ditzel, P. J. Klasse, D. R. Burton, and Q. J. Sattentau Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity J. Virol., May 1, 1998; 72(5): 3512 - 3519. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
